Highlight your company in a strategic location in the BIO Exhibition! Product Focus Zones highlight different areas of expertise and position your company as a leader in your field.
The process of developing and manufacturing biotherapeutics can be divided into upstream processing and downstream processing. Exhibitors in this area have the technologies driving these processes and specialize in the following:
Biotechnology and pharmaceutical companies face many challenges today. One of those is increased cost of research and development and manufacturing of their innovations. Many suppliers are available in the Contract Services Zone to handle early stage research and expedite small to large scale manufacturing services for the biotechnology industry. Suppliers in the Contract Services Zone can satisfy your needs in the following areas:
Healthcare is becoming increasingly patient-centric as stakeholders seek solutions that are broader than just medication. From the drug development process to prescription management and medication compliance, digital health companies can help you develop the cost effective, patient-centric solutions that are now in demand. In the Digital Health Zone, you will find:
What does it take to bring an innovative biotechnology company from discovery to full scale production? Tools for research and development are key in making this transition. Life science companies demand efficiency of data movement and tracking like never before. The exhibitors in the Discovery Zone will offer new and unique techniques for development your innovation focusing on:
The BIO International Convention has partnered with the National Institutes of Health and the National Science Foundation to feature Small Business Innovation Research (SBIR) funded early-stage biotech companies in a newly-created Innovation Zone. The Small Business Innovation Research (SBIR) program provides U.S. federal funding to small businesses engaged in Research/R&D with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to receiving the funding. The majority of participating companies in the Innovation Zone have received SBIR Phase II grants, which provide up to $1 million dollars in funding to engage in R&D that has the potential for commercialization.